Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chagas Disease Diagnostic Applications
Virginia Balouz, Fernán Agüero, Carlos A. Buscaglia
Advances in Parasitology/Advances in parasitology (2016), pp. 1-45
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Treatment of Chagas Disease in the United States
Sheba Meymandi, Salvador Hernández, Sandy Park, et al.
Current treatment options in infectious diseases/Current treatment options in infectious disease (2018) Vol. 10, Iss. 3, pp. 373-388
Open Access | Times Cited: 89
The current drug discovery landscape for trypanosomiasis and leishmaniasis: Challenges and strategies to identify drug targets
Fernando Altamura, Rishi Rajesh, Carolina Moura Costa Catta‐Preta, et al.
Drug Development Research (2020) Vol. 83, Iss. 2, pp. 225-252
Closed Access | Times Cited: 75
Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection
Alba Abràs, Cristina Ballart, Anna Fernández‐Arévalo, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 2
Open Access | Times Cited: 47
New insights into Trypanosoma cruzi genetic diversity, and its influence on parasite biology and clinical outcomes
Marina Malheiros Araújo Silvestrini, Gláucia Diniz Alessio, Bruna Estefânia Diniz Frias, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Chagas disease in the United States: a call for increased investment and collaborative research
Nelson Iván Agudelo Higuita, Norman Beatty, Colin Forsyth, et al.
The Lancet Regional Health - Americas (2024) Vol. 34, pp. 100768-100768
Open Access | Times Cited: 9
Why hasn’t there been more progress in new Chagas disease drug discovery?
Alane Beatriz Vermelho, Giseli Capaci Rodrigues, Claudiu T. Supuran
Expert Opinion on Drug Discovery (2019) Vol. 15, Iss. 2, pp. 145-158
Closed Access | Times Cited: 65
Trypanocidal treatment of Chagas disease
José A. Pérez‐Molina, Clara Crespillo‐Andújar, Pau Bosch‐Nicolau, et al.
Enfermedades Infecciosas y Microbiología Clínica (2020) Vol. 39, Iss. 9, pp. 458-470
Closed Access | Times Cited: 62
What Do You Need to Know before Studying Chagas Disease? A Beginner’s Guide
José A. De Fuentes-Vicente, Nancy G. Santos-Hernández, Christian Ruiz-Castillejos, et al.
Tropical Medicine and Infectious Disease (2023) Vol. 8, Iss. 7, pp. 360-360
Open Access | Times Cited: 20
The Trypanosoma cruzi Antigen and Epitope Atlas: antibody specificities in Chagas disease patients across the Americas
Alejandro D. Ricci, Leonel Bracco, Emir Salas‐Sarduy, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Prevalence and diagnostic accuracy of different diagnostic tests for Chagas disease in an indigenous community of the Paraguayan Chaco
Sofía Ardiles-Ruesjas, Vidalia Lesmo, Valeria González-Romero, et al.
PLoS neglected tropical diseases (2025) Vol. 19, Iss. 2, pp. e0012861-e0012861
Open Access
A prophylactic α-Gal-based glycovaccine effectively protects against murine acute Chagas disease
Susana Portillo, Brenda G. Zepeda, Eva Iniguez, et al.
npj Vaccines (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 48
A review of biological and pharmacological activities of Baccharis trimera
Ana Carolina Silveira Rabêlo, Daniela Caldeira Costa
Chemico-Biological Interactions (2018) Vol. 296, pp. 65-75
Closed Access | Times Cited: 47
Detection of Rare Objects by Flow Cytometry: Imaging, Cell Sorting, and Deep Learning Approaches
Denis V. Voronin, Anastasiia Kozlova, Roman A. Verkhovskii, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2323-2323
Open Access | Times Cited: 41
Chagas Disease Ecology in the United States: Recent Advances in UnderstandingTrypanosoma cruziTransmission Among Triatomines, Wildlife, and Domestic Animals and a Quantitative Synthesis of Vector–Host Interactions
Rachel E. Busselman, Sarah A. Hamer
Annual Review of Animal Biosciences (2021) Vol. 10, Iss. 1, pp. 325-348
Open Access | Times Cited: 34
Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes
Juan Mucci, Santiago J. Carmona, Romina Volcovich, et al.
PLoS neglected tropical diseases (2017) Vol. 11, Iss. 10, pp. e0005972-e0005972
Open Access | Times Cited: 41
Epidemiology and pathogenesis of maternal-fetal transmission of Trypanosoma cruzi and a case for vaccine development against congenital Chagas disease
Lizette E. Rios, Emilia Campos, Ramkumar Menon, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2019) Vol. 1866, Iss. 3, pp. 165591-165591
Open Access | Times Cited: 35
A systematic review of historical and current trends in Chagas disease
Diego-Abelardo Álvarez-Hernández, Rodolfo García-Rodríguez-Arana, Alejandro Ortiz-Hernández, et al.
Therapeutic Advances in Infectious Disease (2021) Vol. 8
Open Access | Times Cited: 27
Accuracy of Diagnostic Tests for the Detection of Chagas Disease: A Systematic Review and Meta-Analysis
Mayron Antonio Candia-Puma, Laura Yesenia Machaca-Luque, Brychs Milagros Roque-Pumahuanca, et al.
Diagnostics (2022) Vol. 12, Iss. 11, pp. 2752-2752
Open Access | Times Cited: 20
Efficacy and Safety of Nifurtimox in Pediatric Patients with Chagas Disease: Results at 4-Year Follow-Up in a Prospective, Historically Controlled Study (CHICO SECURE)
Jaime Altcheh, Víctor Parra Sierra, Teresa Ramirez, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 4
Open Access | Times Cited: 10
A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients
Maan Zrein, Elodie Granjon, Lucie Gueyffier, et al.
PLoS neglected tropical diseases (2018) Vol. 12, Iss. 2, pp. e0006226-e0006226
Open Access | Times Cited: 35
Introducing automation to the molecular diagnosis of Trypanosoma cruzi infection: A comparative study of sample treatments, DNA extraction methods and real-time PCR assays
Alba Abràs, Cristina Ballart, Teresa Llovet, et al.
PLoS ONE (2018) Vol. 13, Iss. 4, pp. e0195738-e0195738
Open Access | Times Cited: 33
Monitoring the parasite load in chronic Chagas disease patients: comparison between blood culture and quantitative real time PCR
Daniella Alchaar D’Ávila, Lúcia Maria da Cunha Galvão, Giovane Rodrigo Sousa, et al.
PLoS ONE (2018) Vol. 13, Iss. 11, pp. e0208133-e0208133
Open Access | Times Cited: 30
Trypanosoma cruzi surface mucins are involved in the attachment to the Triatoma infestans rectal ampoule
María de los Milagros Cámara, Virginia Balouz, Camila Centeno Cameán, et al.
PLoS neglected tropical diseases (2019) Vol. 13, Iss. 5, pp. e0007418-e0007418
Open Access | Times Cited: 25
Prediction of parasitological cure in children infected with Trypanosoma cruzi using a novel multiplex serological approach: an observational, retrospective cohort study
J. Medina, Emeric Chassaing, Griselda Ballering, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 8, pp. 1141-1150
Closed Access | Times Cited: 18
New metabolic signature for Chagas disease reveals sex steroid perturbation in humans and mice
Makan Golizeh, John Nam, Eric Chatelain, et al.
Heliyon (2022) Vol. 8, Iss. 12, pp. e12380-e12380
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top